Haoxi Health (HAO) Fundamental Analysis: Revenue, Earnings & Valuation

0.36 / 10

Underperform

Fundamental assessment rates HAO as Underperform with a 0.4/10 score. Inventory turnover days (213) and operating cycle (3.77) are favorable, yet net‑asset‑per‑share growth is extreme (1615) and historically yields negative returns. Net profit ratio (93.5%) is modest, suggesting prudent positioning.

Analysis Checks(3/4)

Net assets per share (growth rate compared to beginning of year %)

Value1615.81

Score0/3

Weight226.32%

1M Return-3.55%

Operating cycle

Value3.77

Score2/3

Weight-52.07%

1M Return0.82%

Inventory turnover days

Value213.26

Score3/3

Weight-16.48%

1M Return0.24%

Net profit / Total profit (%)

Value93.47

Score2/3

Weight-57.77%

1M Return0.81%

Is HAO fundamentally strong?

HAO scores 0.36/10 on fundamentals and holds a Premium valuation at present. Backed by its 27.06% ROE, 11.82% net margin, 15.49 P/E ratio, 3.46 P/B ratio, and 56.60% earnings growth, these metrics solidify its Underperform investment rating.